We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/news

news

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Proteomic and Metabolomic Insights into Cardiac Remodeling in Breast Cancer Patients Undergoing Cardiotoxic Therapy
CardiologyCardiotoxicitymetabolomics

Proteomic and Metabolomic Insights into Cardiac Remodeling in Breast Cancer Patients Undergoing Cardiotoxic Therapy

By MedXY|Sep 19, 2026

This study identifies novel proteomic and metabolomic biomarkers linked to cardiac dysfunction and remodeling in breast cancer patients treated with cardiotoxic therapies, revealing potential pathways for early detection and intervention.

Intracoronary Imaging-Guided PCI: Updated Meta-Analysis Validates Cardiovascular Outcome Benefits
CardiologyPercutaneous Coronary InterventionIntracoronary Imaging

Intracoronary Imaging-Guided PCI: Updated Meta-Analysis Validates Cardiovascular Outcome Benefits

By MedXY|Sep 19, 2026

This updated meta-analysis of 28 RCTs reveals significant reductions in cardiovascular events and mortality with intracoronary imaging-guided PCI versus angiography-guided PCI, highlighting the importance of lesion and geographic factors in

Unraveling Mitochondrial Dysfunction in RBM20-Related Dilated Cardiomyopathy: The Role of Dysregulated Ribonucleoprotein Granules
CardiologyRBM20ribonucleoprotein granules

Unraveling Mitochondrial Dysfunction in RBM20-Related Dilated Cardiomyopathy: The Role of Dysregulated Ribonucleoprotein Granules

By MedXY|Sep 19, 2026

This article reviews novel research showing how cytoplasmic mislocalization of RBM20 impairs mitochondrial function, leading to severe dilated cardiomyopathy and highlighting distinct mechanisms between gain- and loss-of-function RBM20 vari

Targeting the CCND1-PDK4 Axis to Promote Reparative Macrophage Phenotype and Mitigate Post-Myocardial Infarction Cardiac Remodeling
CardiologyMetabolic Reprogrammingマクロファージ極性化

Targeting the CCND1-PDK4 Axis to Promote Reparative Macrophage Phenotype and Mitigate Post-Myocardial Infarction Cardiac Remodeling

By MedXY|Sep 19, 2026

This article discusses the role of cyclin D1 (CCND1) in promoting reparative macrophage transition post-myocardial infarction, highlighting its therapeutic potential in reducing adverse cardiac remodeling through metabolic reprogramming.

Unlocking the Potential of Novel Biomarkers for Acute Kidney Injury in the Critically Ill: A Comprehensive Evidence Mapping
Critical Carecritical carebiomarkers

Unlocking the Potential of Novel Biomarkers for Acute Kidney Injury in the Critically Ill: A Comprehensive Evidence Mapping

By MedXY|Sep 18, 2026

This article reviews over 1100 studies on novel biomarkers for acute kidney injury (AKI) in critically ill patients, highlighting their predictive, diagnostic, and management roles while identifying gaps for future clinical implementation.

Evaluating the Impact of Relative Value Unit-Based Compensation on Emergency Physician Performance and Operational Outcomes
Emergency MedicineHealthcare OperationsPhysician Compensation

Evaluating the Impact of Relative Value Unit-Based Compensation on Emergency Physician Performance and Operational Outcomes

By MedXY|Sep 18, 2026

A national study examining the shift from hourly to RVU-based pay for emergency physicians found no significant changes in productivity, billing intensity, or key operational metrics, suggesting compensation models may not strongly influenc

Facilitators and Barriers of Using Smart Bedside Station Systems Among Hospitalized Patients: A Qualitative Study Based on UTAUT
Internal MedicinePatient EngagementUTAUT

Facilitators and Barriers of Using Smart Bedside Station Systems Among Hospitalized Patients: A Qualitative Study Based on UTAUT

By MedXY|Sep 18, 2026

This study explores factors that promote or hinder hospitalized patients’ use of Smart Bedside Station systems, revealing that nursing support and useful video education encourage use, while cognitive and workflow challenges limit sus

Optimizing Palliative Care for Effective Hospice Transitions in Cancer Patients: Insights from Multicenter Qualitative and Quantitative Evidence
Clinical Updatescancerhospice transitions

Optimizing Palliative Care for Effective Hospice Transitions in Cancer Patients: Insights from Multicenter Qualitative and Quantitative Evidence

By MedXY|Sep 15, 2026

This review synthesizes evidence identifying critical programmatic factors, relational dynamics, and interventions enhancing hospice transitions in cancer palliative care, emphasizing collaborative oncology-palliative care relationships and

KDIGO 2026 on Anemia in CKD: Key Recommendations and Practical Guidance for Clinicians
Internal Medicineiron therapyerythropoiesis-stimulating agents

KDIGO 2026 on Anemia in CKD: Key Recommendations and Practical Guidance for Clinicians

By MedXY|Sep 18, 2026

KDIGO 2026 updates anemia care in CKD: evidence-based thresholds for iron therapy, preference for IV iron on hemodialysis, ESA-first approach over HIF-PHIs, individualized Hb initiation, and an ESA maintenance upper Hb target <11.5 g/dL.

Optimizing Autologous Stem Cell Backup Mobilization with GCSF and Plerixafor in Sickle Cell Disease: Implications for Gene Therapy
Hematology-Oncologygene therapysickle cell disease

Optimizing Autologous Stem Cell Backup Mobilization with GCSF and Plerixafor in Sickle Cell Disease: Implications for Gene Therapy

By MedXY|Sep 18, 2026

A retrospective study demonstrates the safety and efficacy of GCSF and plerixafor for CD34+ stem cell mobilization as autologous backup in sickle cell patients undergoing alternate donor HSCT, with insights relevant for gene therapy.

Efficacy and Safety of All-Oral Ixazomib, Pomalidomide, and Dexamethasone in Triple-Class Exposed Multiple Myeloma: Insights from a Phase II Study
Hematology-Oncologyrelapsed/refractoryixazomib

Efficacy and Safety of All-Oral Ixazomib, Pomalidomide, and Dexamethasone in Triple-Class Exposed Multiple Myeloma: Insights from a Phase II Study

By MedXY|Sep 18, 2026

This phase II study evaluates the all-oral ixazomib-pomalidomide-dexamethasone regimen in triple-class exposed relapsed/refractory multiple myeloma patients, demonstrating promising efficacy and manageable safety in an elderly and high-risk

Asciminib as a Robust Treatment Option for BCR::ABL1 T315I-Mutated Chronic Myeloid Leukemia: Final Phase 1 Trial Outcomes
Hematology-OncologyAsciminibChronic Myeloid Leukemia

Asciminib as a Robust Treatment Option for BCR::ABL1 T315I-Mutated Chronic Myeloid Leukemia: Final Phase 1 Trial Outcomes

By MedXY|Sep 18, 2026

Long-term phase 1 data confirm asciminib’s efficacy and safety in treating CML-CP patients harboring the resistant BCR::ABL1 T315I mutation, with sustained major molecular responses and manageable adverse events over nearly six years.

Harnessing Type-I Interferon-Activated NK Cells: A Novel Immunotherapeutic Approach to Polycythemia Vera
Hematology-OncologyJak2VF mutationNatural Killer Cells

Harnessing Type-I Interferon-Activated NK Cells: A Novel Immunotherapeutic Approach to Polycythemia Vera

By MedXY|Sep 18, 2026

This article explores how type-I interferon activates NK cells to control polycythemia vera progression, revealing insights into immune modulation and therapeutic potential in myeloproliferative neoplasms.

Rademikibart and Eosinophil Counts in Moderate-to-Severe Asthma: Insights from a Phase 2b Randomized Trial
Allergy & ImmunologyEosinophilsRademikibart

Rademikibart and Eosinophil Counts in Moderate-to-Severe Asthma: Insights from a Phase 2b Randomized Trial

By MedXY|Sep 18, 2026

This article reviews exploratory analyses from a phase 2b trial examining eosinophil count changes in adults with uncontrolled moderate-to-severe asthma treated with the IL-4Rα inhibitor rademikibart, indicating a low risk of treatment-emer

Decoding Pseudomonas aeruginosa Subtypes: Implications for Clinical Variability in Bronchiectasis
Infectious Diseasesbronchiectasismicrobiome

Decoding Pseudomonas aeruginosa Subtypes: Implications for Clinical Variability in Bronchiectasis

By MedXY|Sep 18, 2026

Distinct Pseudomonas aeruginosa abundance and interaction patterns in bronchiectasis patients reveal heterogeneity influencing clinical outcomes and treatment responses, offering new avenues for personalized management.

One-Year Outcomes of WaveLight Plus InnovEyes Ray-Tracing-Guided LASIK: Precision Refractive Correction for Myopia and Myopic Astigmatism
newsLASIKrefractive surgery

One-Year Outcomes of WaveLight Plus InnovEyes Ray-Tracing-Guided LASIK: Precision Refractive Correction for Myopia and Myopic Astigmatism

By MedXY|Sep 18, 2026

This prospective study demonstrates that WaveLight Plus InnovEyes ray-tracing-guided LASIK achieves excellent safety, efficacy, and astigmatic correction precision in treating myopia and myopic astigmatism over one year.

Evaluating the Utility of Routine Tonsil Pathology in a Safety-Net Hospital: Low Yield of Unexpected Malignancies Supports Risk-Stratified Approach
newspathologyclinical assessment

Evaluating the Utility of Routine Tonsil Pathology in a Safety-Net Hospital: Low Yield of Unexpected Malignancies Supports Risk-Stratified Approach

By MedXY|Sep 18, 2026

A retrospective cohort study at a safety-net hospital found that routine pathological examination of tonsillectomy specimens rarely reveals unexpected malignancies, supporting targeted pathology based on clinical assessment.

Rising Early-Onset Colorectal Cancer and Persistent Racial Disparities Despite Increased Colonoscopy Use
Gastroenterologyracial disparitiesearly-onset colorectal cancer

Rising Early-Onset Colorectal Cancer and Persistent Racial Disparities Despite Increased Colonoscopy Use

By MedXY|Sep 18, 2026

From 2017 to 2023, colonoscopy use increased notably in adults under 50. Yet, early-onset colorectal cancer rates and racial disparities, particularly among Black and Hispanic populations, worsened, highlighting that screening alone does no

Integrative Muscle-Adipose Score (IMAS): Enhancing Sex-Sensitive Prognostication After Liver Transplantation
Gastroenterologyliver transplantationbody composition

Integrative Muscle-Adipose Score (IMAS): Enhancing Sex-Sensitive Prognostication After Liver Transplantation

By MedXY|Sep 18, 2026

The Integrative Muscle-Adipose Score (IMAS) combines muscle and fat measures into a sex-specific tool that accurately predicts long-term survival and postoperative complications in liver transplant recipients, outperforming existing models.

Harnessing Kynurenic Acid and the Gut-Brain Axis to Improve Stroke Recovery
GastroenterologyneuroprotectionKynurenic acid

Harnessing Kynurenic Acid and the Gut-Brain Axis to Improve Stroke Recovery

By MedXY|Sep 18, 2026

Kynurenic acid (KYNA) reduction in the gut correlates with worse poststroke outcomes. Supplementation activates a gut-brain neural circuit via GPR35 and the vagus nerve, promoting neuroprotection and functional recovery after ischemic strok

Prev
2 / 25
1234…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles